Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 15308-15309 [2016-06348]
Download as PDF
<![CDATA[
15308
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
Time and Date
12:00 p.m.–3:00 p.m., EDT, April 14,
2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Study to Assess the Incidence of Type
1 Diabetes in Young Adults’’, DP16–005.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06351 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors, National Center
for Environmental Health/Agency for
Toxic Substances and Disease
Registry (BSC, NCEH/ATSDR)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for membership on the
BSC, NCEH/ATSDR.
The BSC, NCEH/ATSDR consists of
16 experts knowledgeable in the field of
environmental public health or in
related disciplines, who are selected by
the Secretary of the U.S. Department of
Health and Human Services (HHS). The
BSC, NCEH/ATSDR provides advice
and guidance to the Secretary, HHS; the
Director, CDC; and the Director, NCEH/
ATSDR, regarding program goals,
objectives, strategies, and priorities in
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
fulfillment of the agencies’ mission to
protect and promote people’s health.
The Board provides advice and
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the Board’s
objectives. Nominees will be selected
from experts knowledgeable in the field
of environmental public health or
related disciplines (e.g., environmental
law, preventive medicine,
epidemiology, occupational and
environmental health, environmental
toxicology, environmental justice,
laboratory sciences, risk assessment,
public policy, behavioral social science,
and health economics). Members may
be invited to serve up to four-year terms.
The HHS policy stipulates that
committee membership be balanced in
terms of points of view represented and
the board’s function. Consideration is
given to a broad representation of
geographic areas within the U.S., as well
as gender, all ethnic and racial groups,
persons with disabilities, and several
factors including: (1) The committee’s
mission; (2) the geographic, ethnic,
social, economic, or scientific impact of
the advisory committee’s
recommendations; (3) the types of
specific perspectives required, for
example, those of consumers, technical
experts, the public at-large, academia,
business, or other sectors; (4) the need
to obtain divergent points of view on the
issues before the advisory committee;
and (5) the relevance of State, local, or
tribal governments to the development
of the advisory committee’s
recommendations. Nominees must be
U.S. citizens.
The following information must be
submitted for each candidate: Name,
affiliation, address, telephone number,
and current curriculum vitae and area(s)
of expertise. Email addresses are
requested if available. Nominations
should be sent, in writing, and
postmarked by April 29, 2016 to:
Amanda Malasky and Sandra Malcom,
Committee Management Specialists,
NCEH/ATSDR, CDC, 4770 Buford
Highway (MS–F45), Atlanta, Georgia
30341, Email addresses:
amalasky@cdc.gov and sym6@cdc.gov.
Telephone and facsimile submissions
cannot be accepted.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06347 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement,
RFA–CE–16–002, Research to Advance
Primary Care-Pharmacy Linkage for
Medication Review to Reduce Older
Adult Falls.
Time and Date: 11:30 a.m.–5:00 p.m.,
EDT, April 21, 2016 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research to Advance Primary CarePharmacy Linkage for Medication
Review to Reduce Older Adult Falls’’
FOA Number RFA–EC–16–002.
Contact Person for More Information:
Jane Suen, Dr. P.H., M.S., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341–3724, Telephone: (770)
488–4281.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\22MRN1.SGM
22MRN1
15309
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06348 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities; Proposed Collection;
Comment Request; the National
Maltreatment Reporting System
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity for public comment on
the proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection requirements
relating to the National Maltreatment
Reporting System (NAMRS). The
proposed collection of information tools
may be found in the NAMRS section of
the ACL Web site.
DATES: Submit written or electronic
comments on the collection of
information by: May 23, 2016.
ADDRESSES: Submit electronic
comments on the collection of
information to Stephanie Whittier
Eliason at stephanie.whittiereliason@
acl.hhs.gov.
Submit written comments on the
collection of information to:
Administration for Community Living,
Attention: Stephanie Whittier Eliason,
330 C St SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Stephanie Whittier Eliason at
202.795.7467.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, ACL is publishing notice
of the proposed collection of
information set forth in this document.
Authority
This data collection effort is in
response to the Elder Justice Act of
2009, which amended title XX of the
Social Security Act (42.U.S.C. 13976 et
seq.). These provisions require that the
Secretary of HHS ‘‘collects and
disseminates data annually relating to
the abuse, exploitation, and neglect of
elders in coordination with the
Department of Justice’’ (Sec.
2041(a)(1)(B)), and ‘‘conducts research
related to the provision of adult
protective services’’ (Sec. 2041(a)(1)(D)).
Furthermore, the Elder Justice
Coordinating Council (EJCC) included
as its third recommendation for
increasing federal involvement in
addressing elder abuse, neglect, and
exploitation: Develop a national adult
protective services (APS) system based
upon standardized data collection and a
core set of service provision standards
and best practices.
Background
From 2013–2015, ACL, in partnership
with the U.S. Department of Health &
Human Services’ Office of the Assistant
Secretary for Planning and Evaluation
(ASPE), developed and pilot tested
NAMRS. When implemented, NAMRS
will be the first comprehensive, national
reporting system for APS programs.
NAMRS is intended to collect
quantitative and qualitative data on the
practices and policies of adult
protective services (APS) agencies, as
well as the outcomes of investigations
Number of
respondents
Instrument
Agency Component .........................................................................................
Key Indicators Component ..............................................................................
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
into the maltreatment of older adults
and adults with disabilities.
In developing NAMRS, ACL and
ASPE convened key stakeholders to
identify data elements that are the most
critical for a national system. More than
40 state administrators, researchers,
service providers, and other
stakeholders provided input in focus
group conference calls. Additionally,
more than 30 state representatives from
25 different states met in three in-person
working sessions to discuss the uses of
collected data and the key
functionalities.
A pilot version of NAMRS was tested
in nine (9) diverse states, and refined
based on feedback from the pilot and
additional stakeholder engagement. A
full discussion on the background of
NAMRS, including the development of
the system, the public engagement
process, and the pilot testing can be
found in the NAMRS section of the ACL
Web site.
Proposed Collection Effort
NAMRS has been developed as a
voluntary system to collect annually
both summary and de-identified caselevel data on APS investigations.
NAMRS consists of three components:
(1) ACL proposes to collect
descriptive data on state agency policies
and practices from all states through the
‘‘Agency Component,’’ and
(2) Case-level, non-identifiable data
on persons who receive an investigation
by APS in response to an allegation of
abuse, neglect, or exploitation through
the ‘‘Case Component.’’
(3) For states that are unable to submit
a case-level file through the ‘‘Case
Component,’’ a ‘‘Key Indicators
Component’’ will be available for them
to submit data on a smaller set of core
items.
ACL will provide technical assistance
to states to assist in the preparation of
their data submissions. Respondents
will be state APS agencies and APS
agencies in the District of Columbia,
Puerto Rico, Guam, Northern Marianas
Islands, Virgin Islands, and American
Samoa. No personally identifiable
information will be collected. ACL has
calculated the following burden
estimates (information on how the
estimates were calculated is available in
the NAMRS section of the ACL Web
site):
Number of
responses per
respondent
56
31
E:\FR\FM\22MRN1.SGM
1
1
22MRN1
Average
burden hours
per response
13
40
Total burden
hours
728
1,240
]]>Agencies
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Pages 15308-15309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06348]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement, RFA-CE-
16-002, Research to Advance Primary Care-Pharmacy Linkage for
Medication Review to Reduce Older Adult Falls.
Time and Date: 11:30 a.m.-5:00 p.m., EDT, April 21, 2016 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Research to Advance Primary Care-Pharmacy Linkage for Medication
Review to Reduce Older Adult Falls'' FOA Number RFA-EC-16-002.
Contact Person for More Information: Jane Suen, Dr. P.H., M.S.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63,
Atlanta, Georgia 30341-3724, Telephone: (770) 488-4281.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and
[[Page 15309]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-06348 Filed 3-21-16; 8:45 am]
BILLING CODE 4163-18-P
